Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Yandex is preparing to enter the market of unmanned electric cars

1/23/24 YNDX

Mosgorlombard opened one more branch of the resale market

1/23/24 MGKL

Novabev Group retained its leadership in the vodka market

1/23/24 BELU

CarMoney establishes IT company Smart Horizon LLC

1/23/24 CARM

QIWI launched a new website for investors

1/23/24 QIWI

Yandex transferred its Russian assets to ICAO Yandex

1/23/24 YNDX

PhosAgro concludes SPIC 2.0 for the development of the Balakovo Complex

1/23/24 PHOR

Acron increased marketable product output by 0.5% in 2023

1/22/24 AKRN

Rosimushchestvo increased its stake in TGK-2 to 83.4%

1/22/24 TGKB

Sberbank intends to integrate its services into Lada cars

1/22/24 SBER